Mocellin, Simone
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2025 Rank: 60975
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1846 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 60975 | 69115 |
| Total Cites | 658 | 698 |
| H-index | 11 | 11 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 17 | 17 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 102 | 102 |
| Total Cites to Single+First Authored Papers | 242 | 244 |
| Number of Single+First+Last Authored Papers | 165 | 165 |
| Total Cites to Single+First+Last Authored Papers | 382 | 393 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 616 | 639 |
| Ratio of Total Citations to Distinct Citing Papers | 1.07 | 1.09 |
| Self-Citation Percentage |
5.73%
|
|
Mocellin, Simone
Università degli Studi di Padova,
Italy
2024 Rank: 53013
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1722 out of 334837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53013 | 59302 |
| Total Cites | 660 | 698 |
| H-index | 12 | 12 |
| Hm-index | 5 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 7 | 7 |
| Number of Single+First Authored Papers | 101 | 101 |
| Total Cites to Single+First Authored Papers | 250 | 251 |
| Number of Single+First+Last Authored Papers | 157 | 157 |
| Total Cites to Single+First+Last Authored Papers | 360 | 370 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 624 | 648 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.08 |
| Self-Citation Percentage |
5.44%
|
|
Mocellin, Simone
Università degli Studi di Padova,
Italy
2023 Rank: 43815
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1546 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 43815 | 47817 |
| Total Cites | 694 | 742 |
| H-index | 12 | 13 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 8 | 8 |
| Number of Single+First Authored Papers | 101 | 101 |
| Total Cites to Single+First Authored Papers | 281 | 283 |
| Number of Single+First+Last Authored Papers | 149 | 149 |
| Total Cites to Single+First+Last Authored Papers | 386 | 394 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 654 | 687 |
| Ratio of Total Citations to Distinct Citing Papers | 1.06 | 1.08 |
| Self-Citation Percentage |
6.47%
|
|
Mocellin, Simone
Università degli Studi di Padova,
Italy
2022 Rank: 30629
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1148 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 30629 | 34348 |
| Total Cites | 805 | 866 |
| H-index | 14 | 14 |
| Hm-index | 6 | 6 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 11 | 11 |
| Number of Single+First Authored Papers | 101 | 101 |
| Total Cites to Single+First Authored Papers | 324 | 324 |
| Number of Single+First+Last Authored Papers | 141 | 141 |
| Total Cites to Single+First+Last Authored Papers | 439 | 446 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 738 | 779 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
7.04%
|
|
Mocellin, Simone
Istituto Oncologico Veneto IOV - IRCCS,
Italy
2021 Rank: 29880
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 1074 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 29880 | 30941 |
| Total Cites | 1186 | 1290 |
| H-index | 17 | 19 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 15 | 15 |
| Number of Single+First Authored Papers | 100 | 100 |
| Total Cites to Single+First Authored Papers | 503 | 504 |
| Number of Single+First+Last Authored Papers | 130 | 130 |
| Total Cites to Single+First+Last Authored Papers | 664 | 675 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1101 | 1168 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
8.06%
|
|
Mocellin, Simone
Università degli Studi di Padova,
Italy
2020 Rank: 25517
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 896 out of 230678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25517 | 26743 |
| Total Cites | 963 | 1059 |
| H-index | 16 | 17 |
| Hm-index | 8 | 8 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 9 | 9 |
| Number of Single+First Authored Papers | 100 | 100 |
| Total Cites to Single+First Authored Papers | 439 | 446 |
| Number of Single+First+Last Authored Papers | 127 | 127 |
| Total Cites to Single+First+Last Authored Papers | 569 | 583 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 889 | 947 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.12 |
| Self-Citation Percentage |
9.07%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.